Gyre Therapeutics Inc. Financial Flexibility Index
Gyre Therapeutics Inc. financial flexibility index. Gyre Therapeutics Inc. (GYRE) has a Financial Flexibility Index of 0.13x as of March 2026. Free cash flow of $3.36 Million (operating CF $3.18 Million minus capex $178.00K) represents 0% of total liabilities ($25.03 Million). See Gyre Therapeutics Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Gyre Therapeutics Inc. (2004–2025)
Financial flexibility index of Gyre Therapeutics Inc. from 2004 to 2025. Historical Financial Flexibility Index trend for Gyre Therapeutics Inc. across 22 annual periods. Check GYRE cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Gyre Therapeutics Inc. Financial Flexibility Index by Year (2004–2025)
Gyre Therapeutics Inc. financial flexibility index by year from 2004 to 2025. Year-by-year free cash flow to debt coverage for Gyre Therapeutics Inc.. For the full cash flow conversion analysis, see GYRE operating cash flow.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.09x | $2.20 Million | $1.01 Million | $23.85 Million | ▲ +585.6% |
| 2024 | -0.02x | $-513.00K | $-3.64 Million | $27.00 Million | ▼ -105.7% |
| 2023 | 0.34x | $34.48 Million | $25.89 Million | $102.59 Million | ▼ -73.1% |
| 2022 | 1.25x | $15.68 Million | $10.68 Million | $12.54 Million | ▲ +122.0% |
| 2021 | -5.69x | $-82.92 Million | $-83.75 Million | $14.57 Million | ▼ -95.0% |
| 2020 | -2.92x | $-54.78 Million | $-55.05 Million | $18.78 Million | ▼ -102.4% |
| 2019 | -1.44x | $-43.55 Million | $-43.61 Million | $30.22 Million | ▲ +74.6% |
| 2018 | -5.66x | $-28.18 Million | $-28.55 Million | $4.97 Million | ▼ -148.5% |
| 2017 | -2.28x | $-19.92 Million | $-19.94 Million | $8.74 Million | ▼ -178.7% |
| 2016 | -0.82x | $-18.00 Million | $-18.47 Million | $22.02 Million | ▼ -65.3% |
| 2015 | -0.49x | $-18.85 Million | $-19.12 Million | $38.10 Million | ▲ +95.8% |
| 2014 | -11.83x | $-34.48 Million | $-34.48 Million | $2.91 Million | ▼ -228.9% |
| 2013 | -3.60x | $-40.52 Million | $-40.61 Million | $11.26 Million | ▲ +23.1% |
| 2012 | -4.68x | $-63.91 Million | $-64.24 Million | $13.66 Million | ▼ -376.5% |
| 2011 | -0.98x | $-82.29 Million | $-83.72 Million | $83.84 Million | ▼ -218.5% |
| 2010 | 0.83x | $141.61 Million | $138.30 Million | $170.94 Million | ▲ +961.7% |
| 2009 | -0.10x | $-24.07 Million | $-24.27 Million | $250.39 Million | ▲ +84.9% |
| 2008 | -0.64x | $-26.21 Million | $-28.26 Million | $41.18 Million | ▼ -201.3% |
| 2007 | 0.63x | $29.78 Million | $24.84 Million | $47.38 Million | ▲ +216.7% |
| 2006 | -0.54x | $-8.82 Million | $-9.89 Million | $16.37 Million | ▼ -294.6% |
| 2005 | -0.14x | $-26.00 Million | $-26.25 Million | $190.48 Million | ▼ -1.4% |
| 2004 | -0.13x | $-24.38 Million | $-25.04 Million | $181.17 Million | — |